For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total operating income | - | - | - | 0 |
| Compensation | 830,724 | 1,107,820 | 845,174 | 1,068,838 |
| Professional fees | 277,679 | 302,576 | 237,916 | 368,932 |
| Information technology | 10,305 | 20,662 | 8,175 | 41,835 |
| General and administrative-other | 147,258 | 152,210 | 214,181 | 265,449 |
| Total general and administrative costs | 1,265,966 | 1,583,268 | 1,305,446 | 1,745,054 |
| Research and development costs | 1,121,008 | 1,112,222 | 1,216,762 | 802,991 |
| Total operating costs | 2,386,974 | 2,695,490 | 2,522,208 | 2,548,045 |
| Net operating loss | -2,386,974 | -2,695,490 | -2,522,208 | -2,548,045 |
| Interest income/ (expense), net | 13,716 | 133,737 | 59,185 | 76,557 |
| Other income/(expense) | 3,011 | -198,488 | 176,032 | 111,202 |
| Loss before income taxes | -2,370,247 | -2,760,241 | -2,286,991 | -2,360,286 |
| Income tax benefit | - | -105,205 | - | 0 |
| Net loss | -2,370,247 | -2,655,036 | -2,286,991 | -2,360,286 |
| Basic EPS | -0.28 | -0.316 | -0.27 | -0.28 |
| Diluted EPS | -0.28 | -0.316 | -0.27 | -0.28 |
| Basic Average Shares | 8,458,847 | 8,393,451 | 8,387,250 | 8,377,265 |
| Diluted Average Shares | 8,458,847 | 8,393,451 | 8,387,250 | 8,377,265 |
EXOZYMES INC. (EXOZ)
EXOZYMES INC. (EXOZ)